Matthew B. Yurgelun
Expertise in
19
conditions

Dr. Matthew B. Yurgelun

Oncology
Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street, 
Chestnut Hill, MA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
19
conditions
Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street, 
Chestnut Hill, MA 

Overview

Matthew Yurgelun is an Oncologist practicing medicine in Chestnut Hill, Massachusetts.

Dr. Yurgelun is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Lynch Syndrome, Pancreatic Cancer, Familial Pancreatic Cancer, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 128 peer reviewed articles and participating in 2 clinical trials. Dr. Yurgelun is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MA

Fellowships

Beth Israel Deaconess Hospital, 2009 - 2012

Hospital Affiliations

Brigham And Women Faulkner Hospital
Beth Israel Deaconess Medical Center
North Shore Medical Center -
Brigham And Women's Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street, Chestnut Hill, MA 02459
Other Locations
Dana-Farber Brigham Cancer Center in clinical affiliation with South Shore Health
101 Columbian Street, South Weymouth, MA 02190

Additional Areas of Focus

Dr. Yurgelun has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Esophageal Cancer
Pancreatic Cancer
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Colorectal Cancer
Stomach Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis
Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Erlotinib
Study Phase: Phase 2
View 1 Less Clinical Trial

128 Total Publications

Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment.
Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment.
Journal: The Journal of clinical investigation
Published: August 04, 2026
Similar Doctors
Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Dana-Farber Cancer Institute

450 Brookline Ave, 
Boston, MA 
 (3.9 miles away)
877-442-3324
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (6.5 miles away)
617-724-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

Dana-Farber Cancer Institute

450 Brookline Ave, 
Boston, MA 
 (3.9 miles away)
877-442-3324
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Toni Choueiri is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choueiri is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Choueiri is currently accepting new patients.

Frequently Asked Questions about Dr. Matthew B. Yurgelun

How do I make an appointment with Dr. Matthew B. Yurgelun?

You can book an appointment with Dr. Matthew B. Yurgelun by calling their office at 617-632-6835. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Matthew B. Yurgelun a top-rated expert for Lynch Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew B. Yurgelun is classified as an Elite expert for Lynch Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Matthew B. Yurgelun specialize in?

While Dr. Matthew B. Yurgelun is a Oncology, they have specific expertise in Lynch Syndrome, Pancreatic Cancer, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Matthew B. Yurgelun participate in research or clinical trials?

Yes. Dr. Matthew B. Yurgelun has published 128 articles and abstracts on conditions like Lynch Syndrome. You can view a list of Dr. Matthew B. Yurgelun's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Matthew B. Yurgelun accept my insurance?

Dr. Matthew B. Yurgelun accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-632-6835 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yurgelun's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 10 Advanced Conditions
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile